Clinical Trial Update: Study Assessing QBS72S For Treating Brain Metastases [Phase 2]

View source ↗

Summary

Stanford University is conducting a Phase 2 trial of QBS72S for brain metastases. The study lists brain metastases, breast cancer, lung cancer, and leptomeninge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Disease
• Lung Cancer

Drugs mentioned

• QBS72S

Snippet

Sponsor: Stanford University | Conditions: Brain Metastases, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING